Method of using interferon-like protein ZCYTO21(IL-29) to treat hepatitis B
US7833520B2 · kind B2 · utility
5Cited by
39References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 30, 2009 |
| Grant date | Nov 16, 2010 |
| Priority date | — |
| Expiry date | Nov 30, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to polynucleotide and polypeptide molecules for Zcyto21, an interferon-like protein, which is most closely related to interferon-α at the amino acid sequence level. The present invention also includes antibodies to the Zcyto21 polypeptides, and methods of using the polynucleotides and polypeptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.